NEOGEN CORPNEOGEarnings & Financial Report
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abuse...
NEOG Q2 2026 Key Financial Metrics
Revenue
$224.7M
Gross Profit
$106.7M
Operating Profit
$-5.4M
Net Profit
$-15.9M
Gross Margin
47.5%
Operating Margin
-2.4%
Net Margin
-7.1%
YoY Growth
-2.8%
EPS
$-0.07
Financial Flow
NEOGEN CORP Q2 2026 Financial Summary
NEOGEN CORP reported revenue of $224.7M for Q2 2026, with a net profit of $-15.9M (-7.1% margin). Cost of goods sold was $118.0M, operating expenses totaled $112.1M.
Key Financial Metrics
| Total Revenue | $224.7M |
|---|---|
| Net Profit | $-15.9M |
| Gross Margin | 47.5% |
| Operating Margin | -2.4% |
| Report Period | Q2 2026 |
NEOGEN CORP Annual Revenue by Year
NEOGEN CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $894.7M).
| Year | Annual Revenue |
|---|---|
| 2025 | $894.7M |
| 2024 | $924.2M |
| 2023 | $822.4M |
| 2022 | $527.2M |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $228.8M | $236.8M | $217.0M | $231.3M | $221.0M | $225.5M | $209.2M | $224.7M |
| YoY Growth | 4.8% | -2.1% | -5.3% | 0.7% | -3.4% | -4.8% | -3.6% | -2.8% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.58B | $4.55B | $4.50B | $4.05B | $4.04B | $3.44B | $3.38B | $3.36B |
| Liabilities | $1.44B | $1.40B | $1.37B | $1.39B | $1.38B | $1.37B | $1.26B | $1.26B |
| Equity | $3.15B | $3.14B | $3.14B | $2.67B | $2.66B | $2.07B | $2.12B | $2.10B |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-30.2M | $26.7M | $-17.9M | $40.3M | $19.4M | $16.5M | $10.9M | $19.4M |